IO Biotech Inc.

NASDAQ: IOBT · Real-Time Price · USD
2.15
0.87 (67.97%)
At close: Aug 15, 2025, 3:59 PM
1.93
-10.23%
After-hours: Aug 15, 2025, 04:11 PM EDT

IO Biotech Income Statement

Financials in USD. Fiscal year is January - December.
Fiscal Year FY 2024 FY 2023 FY 2022 FY 2021
Period Ending Dec 31, 2024 Dec 31, 2023 Dec 31, 2022 Dec 31, 2021
Revenue
n/a n/a n/a n/a
Cost of Revenue
849K 756K 540K n/a
Gross Profit
n/a -756K -540K n/a
Operating Income
-95.18M -91.44M -71.42M -41.23M
Interest Income
4.72M 5.88M 1.41M 361.00
Pretax Income
-94.05M -85.23M -70.19M -67.81M
Net Income
-95.49M -86.08M -71.46M -67.88M
Selling & General & Admin
23.69M 23.61M 24.44M 11.08M
Research & Development
71.48M 67.83M 46.99M 30.15M
Other Expenses
n/a n/a n/a n/a
Operating Expenses
95.18M 91.44M 71.42M 41.23M
Interest Expense
n/a n/a 302K 361K
Selling & Marketing Expenses
n/a n/a n/a n/a
Cost & Expenses
-95.18M 91.44M 71.42M 41.23M
Income Tax Expense
1.44M 852K 1.27M 68K
Shares Outstanding (Basic)
65.88M 43.54M 28.82M 28.82M
Shares Outstanding (Diluted)
65.88M 43.54M 28.82M 28.82M
EPS (Basic)
-1.45 -1.98 -2.48 -2.36
EPS (Diluted)
-1.45 -1.98 -2.48 -2.36
EBITDA
-93.2M -91.23M -69.34M -67.45M
EBIT
-94.05M -91.44M -69.88M -67.45M
Depreciation & Amortization
849K 215K 540K 2K